Current Report · Items 3.01 · 8-K
Quanome Technologies, Inc.
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, on January 7, 2026, Lakeside Holding Limited (the “Company”) received written notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, the Company had failed to comply with the minimum bi…
Filed Jul 10, 2026Accepted Jul 10, 2026, 4:15 PM EDTCIK 1996192Accession 0001213900-26-077147
Company context
Quanome Technologies, Inc. (Nasdaq: QNME) focuses on opportunities across Quantum and AI Systems, Quantum Life Sciences - Molecular Discovery, Advanced Nuclear, and Quantum-Safe Cybersecurity. The Company combines commercial initiatives with the development of a global scientific network through its Global Quantum Council and Scientific Advisory Network. Through its subsidiary “XDT” (XDT Infrastructure I, LLC), Quanome is building an AI cloud business to broaden access to advanced computing resources. www.quanometech.com / www.xdt.com
Current securities
Historical securities (1)
Disclosure sections
Items 3.01Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 3.01Item 3.01 - Notice of Delisting
Item 3.01 Notice of Delisting or Failure to
Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
As previously disclosed, on January 7, 2026, Lakeside
Holding Limited (the “Company”) received written notice from the Listing Qualifications Department (the “Staff”)
of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, the Company had failed to comply with the minimum bid
price of $1.00 per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Bid
Price Requirement”), based on the closing bid price of the Company’s common stock for the previous 30 consecutive business
days from November 14 to January 6, 2026. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided with an initial
period of 180 calendar days, or until July 7, 2026, to regain compliance with the Bid Price Requirement.
On July 9, 2026, the Company received a second
notice (the “Second Notice”) from Nasdaq indicating that, while the Company has not yet regained compliance with the Bid Price
Requirement, the Staff has determined that the Company is eligible for an additional 180 calendar day period, or until January 4, 2027
(the “Second Compliance Period”), to regain compliance. According to the Second Notice, the Staff’s determination was
based on (i) the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements
for initial listing on the Nasdaq Capital Market, with the exception of the Bid Price Requirement, and (ii) the Company’s written
notice of its intention to cure the deficiency during the Second Compliance Period by effecting a reverse stock split, if necessary.
If at any time during the Second Compliance Period,
the closing bid price of the Company’s common stock is at least $1.00 per share for a minimum of 10 consecutive business days, Nasdaq
will provide the Company written confirmation of compliance. The Staff may, in its discretion, require the Company to maintain a bid price
of at least $1.00 per share for a period in excess of 10 consecutive business days, but generally no more than 20 consecutive business
days, before determining that the Company has demonstrated an ability to maintain long-term compliance. If the Company chooses to implement
a reverse stock split, it must complete the split no later than 10 business days prior to the expiration of the Second Compliance Period.
If compliance cannot be demonstrated by January 4, 2027, the Staff will provide written notification that the Company’s securities
will be delisted. At that time, the Company may appeal the delisting determination to a Nasdaq Hearings Panel. There can be no assurance
that the Company will regain compliance or otherwise maintain compliance with any of the other listing requirements.
Nasdaq Notice has no immediate effect on the listing
of the Company’s Common Stock on the Capital Market. The Company intends to continue to monitor the closing bid price of its common
stock and may, if appropriate, consider available options to regain compliance with the Bid Price Requirement.